{"transactions":[{"id":784406,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-05-11T20:35:43.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":135690,"price":4.23,"value":573968.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":231042,"source":{"system":"sec-edgar","filing":"0001214659-26-005932","document":"marketforms-73160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005932/marketforms-73160.xml","form_type":"4"}},{"id":788313,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-05-07T21:31:34.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":76147,"price":4.18,"value":318294.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":366732,"source":{"system":"sec-edgar","filing":"0001214659-26-005747","document":"marketforms-73069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005747/marketforms-73069.xml","form_type":"4"}},{"id":809524,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Secretary"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:51:56.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":82500,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001214659-26-004592","document":"marketforms-72926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926004592/marketforms-72926.xml","form_type":"4"}},{"id":848354,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:52:26.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":4.29,"value":214500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-26-003145","document":"marketforms-72464.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003145/marketforms-72464.xml","form_type":"4"}},{"id":848353,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:26.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":40102,"price":4.173,"value":167345.646,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":442879,"source":{"system":"sec-edgar","filing":"0001214659-26-003145","document":"marketforms-72464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003145/marketforms-72464.xml","form_type":"4"}},{"id":848352,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:26.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":482981,"source":{"system":"sec-edgar","filing":"0001214659-26-003145","document":"marketforms-72464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003145/marketforms-72464.xml","form_type":"4"}},{"id":1211721,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-11T21:47:57.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":60000,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-25-004223","document":"marketforms-68569.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004223/marketforms-68569.xml","form_type":"4"}},{"id":1211720,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:47:57.000Z","date":"2025-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10658,"price":2.65,"value":28243.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":402981,"source":{"system":"sec-edgar","filing":"0001214659-25-004223","document":"marketforms-68569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004223/marketforms-68569.xml","form_type":"4"}},{"id":1211719,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:47:57.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":9592,"price":2.65,"value":25418.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":413639,"source":{"system":"sec-edgar","filing":"0001214659-25-004223","document":"marketforms-68569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004223/marketforms-68569.xml","form_type":"4"}},{"id":1211718,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:47:57.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":423231,"source":{"system":"sec-edgar","filing":"0001214659-25-004223","document":"marketforms-68569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004223/marketforms-68569.xml","form_type":"4"}},{"id":1580508,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-12T17:47:17.000Z","date":"2024-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10530,"price":4.88,"value":51386.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":313231,"source":{"system":"sec-edgar","filing":"0001214659-24-004393","document":"marketforms-65147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004393/marketforms-65147.xml","form_type":"4"}},{"id":1583734,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-11T14:36:35.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":67500,"derivative":{"exercise_price":5.68,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001214659-24-004309","document":"marketforms-64690.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004309/marketforms-64690.xml","form_type":"4"}},{"id":1583733,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-11T14:36:35.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":323761,"source":{"system":"sec-edgar","filing":"0001214659-24-004309","document":"marketforms-64690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004309/marketforms-64690.xml","form_type":"4"}},{"id":1811763,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Performance Stock Units","published_at":"2023-08-09T20:30:34.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."}],"balance_after":75000,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-23-010927","document":"marketforms-61884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923010927/marketforms-61884.xml","form_type":"4"}},{"id":1902273,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Performance Stock Units","published_at":"2023-05-05T20:00:31.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent\nearned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the\nlast day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results\nof the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior\nto and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent\nearned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the\nlast day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results\nof the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior\nto and including the last calendar day of the Performance Period."}],"balance_after":75000,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-23-006557","document":"marketforms-61237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923006557/marketforms-61237.xml","form_type":"4"}},{"id":1960665,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-09T20:06:37.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":188761,"source":{"system":"sec-edgar","filing":"0001214659-23-003690","document":"marketforms-59525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923003690/marketforms-59525.xml","form_type":"4"}},{"id":2122042,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-08T15:23:28.000Z","date":"2022-11-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":40000,"derivative":{"exercise_price":0.875,"expiration_date":"2032-11-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001214659-22-013281","document":"marketforms-57371.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465922013281/marketforms-57371.xml","form_type":"4"}},{"id":2235506,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Warrant (Right to Buy)","published_at":"2022-06-10T21:26:02.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":13761,"price":0.13,"value":1788.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13."}],"balance_after":13761,"derivative":{"exercise_price":0.96,"exercise_date":"2022-12-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":13761},"source":{"system":"sec-edgar","filing":"0001628280-22-016871","document":"wf-form4_165489634971386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000162828022016871/wf-form4_165489634971386.xml","form_type":"4"}},{"id":2235505,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T21:26:02.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":13761,"price":0.96,"value":13210.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13."}],"balance_after":38761,"source":{"system":"sec-edgar","filing":"0001628280-22-016871","document":"wf-form4_165489634971386.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000162828022016871/wf-form4_165489634971386.xml","form_type":"4"}},{"id":2335004,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-14T15:25:10.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":160000,"derivative":{"exercise_price":2.55,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001214659-22-003896","document":"marketforms-55762.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465922003896/marketforms-55762.xml","form_type":"4"}},{"id":2788827,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-15T21:10:35.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":75000,"derivative":{"exercise_price":5.3,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-21-003151","document":"marketforms-51879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465921003151/marketforms-51879.xml","form_type":"4"}},{"id":3201953,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-18T20:45:42.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":60000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-20-002747","document":"marketforms-48350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/marketforms-48350.xml","form_type":"4"}},{"id":3201952,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-18T20:45:42.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":14000,"price":1.5446,"value":21624.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple transactions with prices ranging from $1.46 to $1.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001214659-20-002747","document":"marketforms-48350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/marketforms-48350.xml","form_type":"4"}},{"id":3439734,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-08-13T20:30:14.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":10000,"price":4.0747,"value":40747.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple transactions with prices ranging from $4.03 to $4.08. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001214659-19-005183","document":"marketforms-45477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/marketforms-45477.xml","form_type":"4"}},{"id":3618009,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-04T21:50:34.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":100000,"derivative":{"exercise_price":8.05,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-19-001753","document":"marketforms-44353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465919001753/marketforms-44353.xml","form_type":"4"}},{"id":3748633,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-11-29T21:01:45.000Z","date":"2018-11-27","kind":"purchase","acquired":true,"shares":1000,"price":10.57,"value":10570.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001140361-18-044032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/form4.xml","form_type":"4"}},{"id":3816777,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"officer":true,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-09-13T21:43:30.000Z","date":"2018-09-10","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in three annual installments of 25%, 25% and 50% on September 10, 2019, September 10, 2020 and September 10, 2021, respectively, subject in each case to Ms. Braender's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":85000,"derivative":{"exercise_price":18.67,"expiration_date":"2028-09-10","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001140361-18-038414","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036118038414/form4.xml","form_type":"4"}}]}